Bao et al. elucidated that YTHDF1 contributes to the impairment of antitumor immunity through the m6A-p65-CXCL1/CXCR2 axis, thereby enhancing CRC progression. The gene discussed is YTHDF1; the disease is colorectal carcinoma.